2 terminated, 1 completed. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow HTLV-I-Associated Myelopathy: new trials by email Literature Review of HTLV-I-Associated Myelopathy trials Research Report on HTLV-I-Associated Myelopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Tamibarotene - HTLV-I-Associated Myelopathy | Phase 2 / Phase 3 | Terminated | St. Marianna University School of Medicine | 15 | 2011-01-01 | 2026-10-08 |
| The HAM Infliximab Study Infliximab - HTLV-I-associated Myelopathy | Phase 2 | Terminated | Imperial College London | 3 | 2008-10-01 | 2013-04-15 |
| Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial Zidovudine/lamivudine, Placebos - HTLV-I-associated Myelopathy | Phase 2 / Phase 3 | Completed | Imperial College London | 16 | 1999-11-08 | 2021-08-25 |
Paraparesis, Tropical Spastic (3)
Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Deltaretrovirus Infections (3) · HTLV-I Infections (3) · Infections (3) · Myelitis (3) · Nervous System Diseases (3) · Neuroinflammatory Diseases (3) · RNA Virus Infections (3) · Retroviridae Infections (3) · Spinal Cord Diseases (3) · Virus Diseases (3)
Infliximab (1) · lamivudine, zidovudine drug combination (1) · tamibarotene (1)
Imperial College London (2) · St. Marianna University School of Medicine (1)
United Kingdom (2) · Japan (1)
Graham P Taylor, FRCP (1) · Graham P Taylor, MD (1) · Yoshihisa Yamano, MD (1)